蘇州科達(603660.SH)及子公司累計收到政府補助共2547.76萬元
格隆匯9月22日丨蘇州科達(603660.SH)公佈,根據蘇州市高新區經濟發展委員會[2021]124號《關於下達蘇州科達科技股份有限公司蘇州市自主品牌大企業和領軍企業先進技術研究院2020年度建設扶持資金的通知》,2021年9月18日,蘇州科達科技股份有限公司收到先進技術研究院2020年度建設財政扶持資金1550.6萬元。
自2020年9月23日至公吿披露日,公司及公司控股子公司最近連續12個月內累計收到政府補助共計人民幣2547.76萬元(含本次收到的政府補助1550.6萬元),佔公司最近一個會計年度經審計歸屬於上市公司股東淨利潤的29.98%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.